R&D Pipeline: Proprietary Diagnostics

Breakthroughs Coming in the R&D Pipeline

Blood based tests are the future of diagnostics screening. Our TBIA platform represents a cost effective, scalable, and patient friendly screening method for cancer detection.

mammogram-screening-patient-doctor-analysis-1128870494(1)
Videssa® Breast
A cancer blood test designed specifically for the early detection of breast cancer in women with abnormal imaging findings
alzehemier-diagnostics-168715138
LymPro™
Validated blood-based assay for differentiating between non-AD Dementia / Prodromal AD / MCI / Alzheimer’s Disease
iStock-1055996940-web
TolloTest™
Diagnostic coronavirus test that measures 3CL protease from upper respiratory samples
medical-high-tech-analysis-1001817586
TBIA Platform
An AI Platform reading the Immune Response to Cancer

Stay informed of our latest breakthroughs.